$VCYT

Wygant Jonathan sold $1.1M of VCYT

Wygant Jonathan (VP, Chief Accounting Officer) sold 24,000 shares of VERACYTE, INC. (VCYT) at $45.40 ($1.09M total) on 2026-05-22.

Original reporting
SEC EDGAR · Wygant Jonathan
Published May 27, 2026, 8:19 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 27, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VCYT
Neutral
medium confidence
Mentioned
$VCYT
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VCYTNeutralLow
01

Why it matters

Insider selling disclosures can create short-lived sentiment pressure, but without earnings, guidance, or business developments, the trading signal is usually weak.

02

Market read

VCYT-specific insider selling of ~$1.09M is disclosed; absent other catalysts, expected impact is limited to sentiment.

03

What to watch

No 10b5-1 plan is cited, but the article also lacks details on tax, diversification needs, or whether other insiders/funds changed positions around the same time.

Relevance 6/10Timing: Immediate (today’s filing), but likely fades quickly without additional company-specific catalysts.

Background

The article is a SEC Form 4 insider transaction disclosure for Veracyte, Inc. (VCYT).

Company-level read

Ticker impact

$VCYTNeutralMedium confidence
Context

Veracyte CFO Jonathan Wygant filed an open-market sale of 24,000 shares for about $1.09M on 2026-05-22.

Expected impact

Low probability of a sustained move; any reaction is likely brief unless accompanied by other news.

Evidence & confidence

Form 4 insider sales are common and the filing notes no pre-arranged 10b5-1 plan, but the article provides no earnings/guidance or operational catalyst.

Market effects

Minimal; this is company-specific insider activity without sector-wide read-across in the article.

None indicated.

None indicated.

Counterpoint

The sale may be routine liquidity/portfolio rebalancing rather than a negative signal, especially given the absence of any accompanying negative company event in the filing.

Key entities

  • VERACYTE, INC.

    Subject of the Form 4 insider sale by CFO Jonathan Wygant.

  • Jonathan Wygant

    VP, Chief Accounting Officer who sold 24,000 shares in an open-market transaction.

Related articles

$VCYTHigh

VERACYTE, INC. (VCYT): Results of Operations and Financial Condition

VERACYTE, INC. (VCYT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 vcyt-07x30x20268xkearnings.htm EX-99.1 Document Exhibit 99.1 Veracyte Announces Second Quarter 2026 Financial Results Grew total revenue to $150.3 million and testing revenue to $145.7 million, representing increases of 15% and 19% year-over-year, respectively Conferenc